Information:
Fel:
ID
34213
Beskrivning
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01021865
Länk
https://clinicaltrials.gov/show/NCT01021865
Nyckelord
Versioner (1)
- 2019-01-15 2019-01-15 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
15 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Coronary Artery Disease NCT01021865
Eligibility Coronary Artery Disease NCT01021865
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT01021865
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
males and females
boolean
ID.2
Item
age 40-60 years
boolean
ID.3
Item
bmi< or = 35 kg/m2
boolean
ID.4
Item
diabetic subjects with hba1c concentrations of < or = 8%.
boolean
ID.5
Item
diabetic subjects will be either on diet and lifestyle therapy alone, or monotherapy with metformin or sulphonylureas (except glyburide).
boolean
ID.6
Item
all diabetic subjects should be on stable dose oral agent therapy for 3 months prior to enrollment.
boolean
ID.7
Item
subjects with cerebrovascular or peripheral vascular disease.
boolean
ID.8
Item
subjects with suspected or overt autonomic neuropathy.
boolean
ID.9
Item
diabetic subject on thiazolidinediones, insulin, glp-1 based therapies (exenatide or sitagliptin), alpha-glucosidase inhibitors, glyburide or combination antidiabetic drug therapies.
boolean
ID.10
Item
diabetics with microalbuminuria.
boolean